THE HOME FOR BIOPHARMA LAUNCH LEADERS TO REVOLUTIONISE LAUNCH STRATEGY & MANAGEMENT FROM CLINICAL DEVELOPMENT INTO POST-LAUNCH COMMERCIAL SUCCESS
3 - 4 December 2024
| Hotel London Olympia, UK
Laura Wallace
VP, Head of Global Integrated Evidence Boehringer Ingelheim
Laura Wallace is the VP, Head of Global Integrated Evidence at Boehringer Ingelheim. She is an epidemiologist by training, with a background in Psychology, Biochemistry, and Public Health. Laura has worked in the pharmaceutical industry for more than 20 years, in roles including Epidemiology, Safety and Risk Management, Medical Affairs, and Customer Value. Her current team of almost 90 colleagues in the US, Europe, and Asia promotes the use of integrated evidence, with an emphasis on RWE, across stakeholders, across the lifecycle, and around the world to support evidence-based decision making. Laura is based in Ridgefield CT in the US, having recently returned from 4 years at Boehringer Ingelheim headquarters in Ingelheim, Germany.
Pharma Launch Excellence Summit Main Conference Day 1: Tuesday 3rd December
11:30 AM Roundtable Discussion: Health System and Market Strengthening: Alignment, Partnering and Integration for Launch Readiness
Setting the scene: The Centrality of Partnerships for Launch readiness 5 min
Chair : Troels Sørensen - Global Head Clinical Practice, Boehringer Ingelheim
Talk 1 : Target Population Outputs (TPOs) – is the market leady for launch? 7 min
Troels Sørensen – Head of Global Clinical Practice, Boehringer Ingelheim
Talk 2 : Evidence is the product – is the product launch ready ? 7 min
Laura Wallace – Head of Global Integrated Evidence - Boehringer Ingelheim
Talk 3: Engagement and Strategic PPPs at government level: market shaping for launch and uptake of innovations 7 min
Lena Lymperopoulou - Global Policy Executive, ex Novartis / GSK. Founder of the World Economic Forum Strategic PPPs initiative
Talk 4: Partnerships at health body and regional level: Access and launch readiness 7 min
Danny Moore - Strategic Account Director – Novartis
Talk 5: Partnerships at departmental level: Transforming Field medical to impact accountable launch leaders 7 min
Helen Kane – Global Medical Affairs and Field Medical Affairs Executive - ex-Novarts/Roche/Celgene. Founder of One MSL.
Panel discussion and questions 20 min
· Focus on the capabilities required by each respective function
Check out the incredible speaker line-up to see who will be joining Laura.
Download The Latest AgendaIn Partnership With :
QUESTIONS?
Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk
©2024 IQPC. All rights reserved.
